Efavirenz Metabolite E |
|
| Synonyms: rac 8,14-Dihydroxy Efavirenz; 6-Chloro-1,4-dihydro-8-hydroxy-4-[(1-hydroxycyclopropyl)ethynyl]-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; | |
| Cat. No.: E21029 | CAS No.: 1189909-96-3 |
| MDL.: | Formula: C14H9ClF3NO4 |
| F.W.347.67 | Purity: 99% |
| Storage: -20°C Freezer | |
|   | |
| Catalog Number: | E21029 | CAS No.: | 1189909-96-3 | |
| MDL: | Formula: | C14H9ClF3NO4 | ||
| F.W.: | 347.67 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | White Solid | M.P.: | >199°C (dec.) | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Ethyl Acetate, Methanol | Stability: | ||
| Storage: | -20°C Freezer | Category: | Reference Standard | |
| Reference: | Gorski, J., et al.: Biochem. Pharmacol., 47, 1643 (1994), Desta, Z., et al.: J. Pharmacol. Exp. Ther., 285, 428 (1998), Langmann, P., et al.: Eur. J. Med. Res., 7, 309 (2002), Chang, T., et al.: Drug Metab. Dispos., 31, 7 (2003), | |||
| Application: | A metabolite of Efavirenz (secondary metabolism | |||
| Category: | Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, | |||








